Advertisement

Acton Pharmaceuticals Inc., a respiratory therapeutics firm in Marlborough, has appointed two new executives in naming Kenneth Newman as executive vice president, chief medical officer, and Thomas Phair as senior vice president, chief financial officer.

Newman, who will direct the research, development and medical activities at Acton, previously served as vice president at Boehringer Ingelheim. Prior to that, he oversaw pulmonary clinical development at Forest Laboratories. He has a medical degree from the University of Texas and a bachelor’s degree from Duke University.

SOURCE

Advertisement
Advertisement